Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate

OBJECTIVE: The aim of this study was to evaluate the safety of 3-monthly paliperidone palmitate (PP3M) vs once-monthly paliperidone palmitate (PP1M) treatment with regard to extrapyramidal symptom (EPS)-related treatment-emergent adverse events (TEAEs) in patients with schizophrenia, previously stab...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Neuropsychiatr Dis Treat
मुख्य लेखकों: Mathews, Maju, Nuamah, Isaac, Savitz, Adam J, Hough, David W, Najarian, Dean, Kim, Edward, Gopal, Srihari
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2018
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207222/
https://ncbi.nlm.nih.gov/pubmed/30498351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S175364
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन